Gopinath Palanisamy
Vice President, Pharmacology, Dmpk and Toxicology @Olema Oncology
Signup · Get unlimited contacts
WORK HISTORY
Vice President, Pharmacology, Dmpk and Toxicology @Olema Oncology
San Francisco, CA, US
EDUCATION
University of Illinois Urbana-Champaign
MS, Molecular reproductive biology
Colorado State University
PhD and Anatomic Pathology Residency
Tamilnadu Veterinary and Animal Sciences University
DVM, Veterinary Medicine
SKILLS
ABOUT GOPINATH PALANISAMY
An accomplished leader in nonclinical drug development, with extensive experience within both the pharmaceutical/biotechnology industry and academia. Presently, I oversee multiple functions including pharmacology, DMPK, bioanalysis, toxicology, and pathology. As a project team leader, I have spearheaded the advancement of oncology drug discovery programs. I contribute to the strategic direction of the company by actively participating in the selection and thorough due diligence evaluation of potential in-licensing opportunities. Previously, I successfully led nonclinical cross-functional teams throughout all phases of clinical development. My role has often involved representing multiple drug development teams, leveraging my expertise as both a project toxicologist and a board-certified pathologist. Additionally, I have authored numerous regulatory documents, including IND/CTAs and IBs, and represented relevant functions in engagements with regulatory bodies such as the FDA, MHRA, and EMEA.
This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.